IP Holding Company Jurisdiction 2026: Where to Hold IP

Last updated: April 2026

IP holding structures are one of the most discussed — and most misunderstood — tax planning tools for tech founders. The advice circulating in most forums and advisory decks is either outdated, incomplete, or quietly ignores the compliance reality that has existed since 2016.

If you've heard that placing your patents or software IP in a Cyprus or Irish company cuts your effective tax rate to 2.5% or 10%, the broad claim is accurate. What most guides skip is the harder part: doing it correctly now requires genuine operational substance in the holding jurisdiction, a transfer pricing framework, and IP-derived revenue at sufficient scale for the cost to be worthwhile. For many early-stage founders, the structure is not ready yet — and that's worth saying plainly.

This guide covers which jurisdictions have genuine, OECD-compliant IP box regimes in 2026, what substance requirements actually demand in practice, and the revenue threshold at which the structure makes economic sense. It is written for SaaS, software, and tech founders with monetized IP who are evaluating where to hold it.

Note for US citizens and permanent residents: The interaction between foreign IP holding structures and US Subpart F rules and GILTI successor rules (Net CFC Tested Income, effective from the 2026 US tax year for most purposes) adds a layer of complexity that this guide does not cover. If you hold a US passport or green card, you need a US international tax advisor involved from the start — before selecting a jurisdiction.

What is an IP holding structure?

The basic mechanics are straightforward. An operating company — where your customers are, where you generate revenue — pays royalties to a separate IP holding company that legally owns the intellectual property. The IP holding company benefits from a preferential tax rate on that royalty income. The operating company deducts the royalty payment, reducing its taxable profit in what is typically a higher-rate jurisdiction.

This is the IP holding structure in its simplest form. The tax efficiency comes from the difference between the operating company's standard corporate rate (say, 25% in Germany or 19–25% in the UK) and the IP box rate in the holding jurisdiction (2.5% in Cyprus, 9% in the Netherlands, 10% in Ireland).

What qualifies as IP in this context? Under most OECD-aligned regimes:

• Patents — yes
• Copyrighted software — yes (Ireland and Cyprus explicitly; Netherlands with an R&D declaration)
• Trademarks and brand names — no (excluded from all OECD-aligned regimes)
• Trade secrets and undisclosed know-how — varies by jurisdiction
• Marketing intangibles (customer lists, brand equity) — no

The exclusion of trademarks and brand IP is important. Founders whose primary IP is their brand name, rather than patented technology or original code, are largely out of scope for IP box treatment. The regimes are designed for technology, not brand value.

The holding structure also does not mean simply parking IP in a foreign entity with no operations. That was possible before 2016. It is not viable now.

The OECD BEPS reality: why old IP structures no longer work

BEPS Action 5 and the nexus approach

Before 2016, IP could be legally assigned to a zero-tax jurisdiction — a BVI shell, a Cayman entity, a Luxembourg letter-box company — with no employees, no R&D activity, and no genuine presence. Royalties would flow to that entity and be taxed at near-zero rates. This was the pre-BEPS model and it is now effectively dead.

The OECD's Base Erosion and Profit Shifting (BEPS) Action 5 introduced the "modified nexus approach," which requires a direct link between R&D expenditure incurred in the holding jurisdiction and the IP income qualifying for the preferential rate. The formula is: qualifying R&D expenditure (incurred by the taxpayer directly, or outsourced to unrelated third parties — capped at 130% of direct spend) divided by total expenditure to develop the IP, expressed as a ratio. Only that fraction of IP income qualifies for the box rate.

The practical consequence is significant. If you developed all the IP yourself in the jurisdiction, your nexus ratio approaches 100% and you access the full benefit. If you acquired IP from a related party, or outsourced all development to a group entity, your nexus ratio drops sharply and the preferential rate applies to a much smaller portion of income. The structure still exists legally, but the tax benefit shrinks proportionally.

All 135+ jurisdictions in the OECD Inclusive Framework have committed to the BEPS Action 5 minimum standard. The major IP box regimes — Ireland, the Netherlands, Cyprus, Luxembourg — are all now fully compliant with the nexus approach. OECD BEPS Action 5 progress report (February 2026).

DEMPE functions — what "substance" actually means

The nexus approach governs how much of your IP income qualifies. A parallel framework governs where the economic returns from IP should sit. BEPS Actions 8–10 introduced the DEMPE standard — Development, Enhancement, Maintenance, Protection, and Exploitation of intellectual property.

The core principle: legal ownership of IP alone does not entitle an entity to the returns from that IP. The economic returns follow where the key value-creating functions are performed, the costs are borne, and the risks are controlled. If your R&D team is in Berlin, your product managers are in London, and your legal-title holding company is in Cyprus with no employees, the DEMPE analysis points firmly back to Germany and the UK as the economic owners of that IP — regardless of what the holding company's incorporation documents say.

For founders, this means: to access the Cyprus IP box, the Cyprus entity must actually perform meaningful DEMPE functions. That requires real employees whose primary work relates to the IP — software developers, R&D managers, IP counsel — with their employment and management activity genuinely based in Cyprus. A director and a registered office address is not substance. Tax authorities across the EU have challenged and denied letter-box IP arrangements in Cyprus, Luxembourg, and the Netherlands specifically on this basis.

What substance actually requires in practice

The minimum standard for defensible substance in an IP holding jurisdiction includes:

• Qualified employees in the jurisdiction whose primary role relates to the IP (software development, R&D management, IP portfolio management)
• Management and control of IP decisions demonstrably taken in the jurisdiction — not by founders or directors resident elsewhere
• R&D expenditure genuinely incurred in the jurisdiction, documented and attributable
• Transfer pricing documentation demonstrating that the royalty rate between the operating entity and the IP holding entity is at arm's length

Cost reality: Genuine substance in an EU jurisdiction costs €50,000–€200,000 per year in personnel and operational expenses, depending on the jurisdiction and headcount. This is before formation costs, annual compliance, and transfer pricing documentation. The Netherlands and Ireland are at the higher end of that range due to salary levels. Cyprus is at the lower end.

This cost is the most important variable in the cost-benefit analysis — and it is the one that almost no IP holding guide mentions directly.

Best IP holding jurisdictions in 2026

Ireland — Knowledge Development Box (KDB)

Standard rate: 12.5%

KDB effective rate: 10% on qualifying profits

Ireland's KDB rate increased from 6.25% to 10% for accounting periods commencing after October 1, 2023. Most guides published before mid-2024 still cite 6.25% — that figure is now outdated. The Irish Revenue KDB guidance confirms the current rate.

Qualifying assets under the KDB include patents and copyrighted software — a deliberately broad definition that is favorable for SaaS products and mobile applications. The nexus approach is fully implemented and substance requirements apply.

The US-Ireland double tax treaty reduces withholding tax on qualifying royalties paid from a US entity to an Irish holding company to 0%, which makes Ireland particularly compelling for founders with a US operating company or significant US revenue. Ireland is English-language, common law, and home to a large technology employment market — which reduces the friction of building genuine substance there.

Weaknesses: At 10%, the KDB margin over Ireland's standard 12.5% rate is only 2.5 percentage points. The cost savings per euro of qualifying IP income are smaller than in Cyprus or Luxembourg. Employment costs in Dublin are high. The KDB regime is confirmed through January 2027; its extension status should be verified with an advisor.

Best for: Companies with actual R&D teams or expansion plans in Ireland; structures with US parent companies or significant US revenue; founders who want a common-law, English-language EU jurisdiction.

Netherlands — Innovation Box

Standard rate: 19–25.8% (tiered)

Innovation Box rate: 9% on qualifying profits

The Netherlands Innovation Box applies to IP arising from patents or, for smaller companies, from R&D activities supported by a WBSO (R&D tax credit) declaration. Larger companies require a patent in addition to the WBSO declaration to access the regime. The official Netherlands government guidance covers qualifying conditions and documentation requirements.

The Netherlands has one of the strongest treaty networks globally, which matters significantly for withholding tax on inbound royalties. The gap between 9% and the standard rate of up to 25.8% creates meaningful savings on qualifying IP income.

Weaknesses: Trademarks and marketing intangibles are excluded. For companies without existing patents, qualifying for the Innovation Box requires a patent — adding cost and time. The Netherlands introduced a royalty withholding tax in 2021 on royalties paid to related parties in low-tax jurisdictions; the direction of royalty flows and the structure of group entities needs careful review to avoid this charge. Employment costs in Amsterdam and major Dutch cities are comparable to Ireland.

Best for: Tech companies with existing or pending patents; founders who want a high-credibility EU jurisdiction with an excellent treaty network; structures where the royalty flow is into the Netherlands (outbound royalties to a Netherlands holding company are treated differently from the 2021 withholding tax reform than outbound payments from the Netherlands).

Cyprus — IP Box

Standard rate: 15%

IP Box effective rate: approximately 2.5% (80% exemption on the 15% standard rate on qualifying profits)

Cyprus has the lowest effective IP box rate of any OECD-compliant EU jurisdiction. The 80% exemption is applied to net qualifying IP income — royalty revenue less directly attributable costs. Capital gains on the disposal of qualifying IP assets are also exempt from tax in Cyprus, which matters if you are planning to sell a company or IP asset.

Cyprus imposes no withholding tax on royalties paid to foreign entities in most circumstances — an important structural advantage. Within the EU, the Interest and Royalties Directive additionally eliminates withholding tax on qualifying intra-EU royalty payments between related companies.

The nexus approach fully applies. If your Cyprus entity conducted all R&D itself (nexus ratio of 100%), the full 80% exemption is available. If IP was acquired from a related party or developed primarily by offshore developers, the nexus ratio falls and the effective benefit shrinks. Cyprus IP Box compliance requirements for 2026 covers the nexus ratio calculation in detail.

Weaknesses: Cyprus has a smaller labor market for senior R&D and IP management talent than Ireland or the Netherlands. The 15% standard corporate rate (increased from 12.5% in 2023) means the base from which the exemption operates is the same as Ireland's full standard rate — the 2.5% effective rate is compelling, but the headline rate increase is recent and worth noting. Some institutional counterparties (banks, investors, larger corporate partners) view Cyprus as a lower-prestige jurisdiction than Ireland or the Netherlands, which can affect banking relationships and due diligence processes.

Best for: Founders who can credibly place R&D or IP management functions in Cyprus; structures where IP was developed in Cyprus from the outset (strongest nexus position); those for whom substance cost is a primary consideration.

Luxembourg — IP Box

Standard rate: approximately 24.9% (combined rate including municipal business tax)

IP Box effective rate: approximately 5.2% (80% exemption on qualifying income; also full net wealth tax exemption on qualifying IP)

Luxembourg's IP box delivers a more competitive effective rate than Ireland but less competitive than Cyprus. The regime covers patents and copyrighted software; trademarks are excluded. The nexus approach applies fully. Luxembourg's IP regime overview covers the regime mechanics.

Luxembourg is the premier financial structuring jurisdiction in Europe. It carries institutional credibility that Cyprus does not, and its treaty network is exceptional. For corporate groups that already use Luxembourg as a holding jurisdiction, adding IP holding to an existing Luxembourg structure may have lower incremental cost than establishing a new presence in Cyprus.

Weaknesses: Luxembourg is the most expensive EU jurisdiction to establish genuine substance. Employment costs, office costs, and compliance costs are at the high end of the European range. The 5.2% effective rate is better than Ireland but worse than Cyprus, and the cost of achieving it is the highest of any jurisdiction in this comparison. Luxembourg IP box structures are best suited to large corporate groups, not individual founders or small teams.

Best for: MNEs or larger corporate groups with existing Luxembourg presence; structures where Luxembourg already serves as a holding or treasury function; situations where institutional credibility and treaty network outweigh cost efficiency.

Singapore — IP Development Incentive (IDI)

Standard rate: 17%

IDI rate: 5%, 10%, or 15% on qualifying IP income (tiered by commitment level)

Singapore's IDI is awarded by the Economic Development Board (EDB) and is not automatic. Companies apply for the incentive and must commit to incremental job creation and investment in Singapore. The lowest tier (5% rate) requires the most significant commitments. EDB Singapore IDI factsheet covers tier requirements.

Singapore has strong legal infrastructure, a common law system, no withholding tax on royalties in many circumstances, and a treaty network that covers most major Asian jurisdictions effectively.

Weaknesses: The discretionary nature of IDI — EDB must approve the application — makes planning uncertain in a way that Ireland, Cyprus, or the Netherlands do not. Significant headcount and investment commitments are required. Singapore is most relevant for founders with genuine APAC operations or commercialization; for EU-focused SaaS businesses, it adds complexity without proportional benefit.

Best for: Tech companies with genuine APAC operations, customers, or R&D functions; founders building R&D centers in Singapore; structures where APAC commercialization is central to the business.

Jurisdiction comparison table

What no longer works

Several approaches that were common before 2016 are now either ineffective or actively risky:

Zero-tax shell holding. Assigning IP to a BVI, Cayman, or Bermuda entity with no employees and no R&D activity produces a nexus ratio of zero. The holding entity performs no DEMPE functions. Tax authorities in the operating company's jurisdiction will challenge the royalty deductions on the grounds that the structure lacks economic substance. There is no IP box benefit in these jurisdictions in any case — they have no preferential regime, just a zero or near-zero standard rate that no longer passes muster under BEPS.

Pre-BEPS Luxembourg and Cyprus letter-box arrangements. Both Luxembourg and Cyprus had IP regimes before 2016 that required no substance. These were abolished and grandfathering periods expired years ago. Any structure created before 2016 that has not been reviewed against current nexus and DEMPE requirements needs urgent review.

Trademark or brand IP holding. All OECD-aligned IP box regimes explicitly exclude marketing intangibles — trademarks, brand names, customer lists. Moving brand IP offshore creates royalty complexity and withholding tax exposure with no preferential rate on the other end. It is an expensive structure that delivers no IP box benefit.

Acquiring IP into a new IP holding entity. Buying IP and transferring it into a new IP box jurisdiction generates a very low nexus ratio, because the R&D expenditure was not incurred in the new jurisdiction. It also requires a full transfer pricing valuation of the IP at arm's length at the point of transfer — a significant compliance cost that often eliminates the expected benefit.

Paper substance. A local director, a registered office, and no real employees or R&D. Tax authorities examine where key personnel are located, where decisions are made, and where IP development actually occurs. Director-only structures without genuine operational presence fail the substance test under all OECD-aligned regimes.

Royalty payments and withholding tax

The IP box rate you achieve in your holding jurisdiction is the rate on income that arrives there. Before it arrives, the operating company's jurisdiction may impose withholding tax on outbound royalty payments. That withholding tax can substantially reduce — or eliminate — the effective saving.

Without a tax treaty, withholding tax rates on royalty payments are commonly 10–25%. With a well-structured treaty or EU directive access, the rate falls to 0–5%.

Key examples:

• A US operating company paying royalties to an Irish IP holding company: the US-Ireland double tax treaty reduces US withholding tax on qualifying royalties to 0%, subject to treaty conditions.
• An EU operating company paying royalties to a Cyprus IP holding company: the EU Interest and Royalties Directive eliminates withholding tax on qualifying intra-EU royalty payments between related companies.
• An Asian operating company paying royalties to a Singapore IP holding company: Singapore's treaty network covers most major APAC jurisdictions with reduced rates.

This means the treaty network of the holding jurisdiction is not a secondary consideration — it is a primary one. Founders with US revenue and operations should weigh Ireland's US treaty heavily. Founders with EU operating companies have access to the EU Interest and Royalties Directive from Cyprus, Ireland, the Netherlands, and Luxembourg equally.

Transfer pricing is a mandatory parallel requirement. The royalty rate paid between the operating entity and the IP holding entity must be set at arm's length — meaning it reflects what unrelated parties would agree to. Unsupported or undocumented royalty rates are a primary audit trigger in every major jurisdiction. Initial transfer pricing documentation typically costs €8,000–€30,000 to establish.

Cost vs. benefit: when an IP holding structure makes sense

The structure is an optimization tool, not a starting point. The honest analysis compares annual tax savings against the total cost of genuine substance.

Annual substance costs:

• Salaries for qualified employees whose work is attributable to IP (minimum one to two FTE): €40,000–€120,000 depending on jurisdiction and seniority
• Office space and operational costs: €5,000–€20,000
• Annual entity compliance, accounting, and audit: €8,000–€25,000
• Transfer pricing documentation maintenance: €5,000–€15,000 per year after initial setup
• Total range: €50,000–€200,000+ per year

One-time setup costs:

• IP valuation at transfer (if moving existing IP): €5,000–€25,000 depending on asset complexity
• Initial transfer pricing study: €8,000–€30,000
• Entity formation and legal setup: €5,000–€15,000

Revenue threshold analysis

The annual tax saving depends on three variables: the IP-derived royalty revenue, the difference between the operating company's standard rate and the IP box rate, and the nexus ratio. The table below uses realistic estimates.

Worked example: An Irish operating company with €1.5M in qualifying IP income uses the KDB. Effective saving: 12.5% standard rate minus 10% KDB rate = 2.5 percentage points. On €1.5M, that is €37,500 per year. Genuine substance in Ireland costs a minimum of €60,000–€100,000 per year. The math does not work.

The same structure with €5M in qualifying IP income: saving of 2.5% on €5M = €125,000 per year. Substance costs of €80,000 per year. The structure delivers a net benefit of approximately €45,000 per year before setup amortization. That is a defensible case.

At the Cyprus rate of 2.5% vs. a German operating company rate of 29.9%, the saving per euro of qualifying income is far larger — approximately 27 percentage points — and the substance cost is lower. Cyprus becomes economically viable at a lower revenue threshold, provided genuine substance can be established.

The important caveat: If you are already building an R&D team in a qualifying jurisdiction for genuine operational reasons — not for tax purposes — the incremental cost of accessing the IP box may be minimal. In that case, the revenue threshold drops significantly. The structure makes much more sense when it follows operational reality than when it creates it.

What qualifies for IP box treatment

Who this is NOT for

This section exists because most IP holding guides never say it plainly. These structures are not appropriate for everyone considering them.

Founders with IP revenue below €1–2M annually. The cost of genuine substance almost certainly exceeds the tax saving at this revenue level. The structure is not ready for you yet — focus on growing revenue first, document your R&D activity carefully, and revisit the analysis when the numbers change.

Founders who cannot place genuine R&D activity in the holding jurisdiction. If your entire development team is in India, Germany, or the US, and there is no realistic path to meaningful IP development or management activity in Cyprus or Ireland, the nexus ratio will be very low and the substance test will fail. You cannot access an IP box by creating a legal entity in a jurisdiction where no real work happens.

Founders holding primarily trademark or brand IP. Trademarks and brand names are explicitly excluded from IP box treatment under every OECD-aligned regime. If your IP is primarily brand-driven rather than technology- or patent-driven, IP holding structures do not apply. Creating an offshore entity to receive trademark royalties creates complexity and withholding tax exposure without any preferential rate benefit.

US citizens and permanent residents. As noted in the introduction, the interaction between foreign IP holding structures and US Subpart F rules and the GILTI successor regime adds significant complexity. US persons may find that profits in a foreign IP holding company are treated as immediately taxable in the US regardless of the holding jurisdiction. This analysis requires a US international tax attorney and falls outside the scope of this guide.

Founders in high-CFC jurisdictions. France, Germany, the UK, and Australia all have controlled foreign corporation (CFC) rules that can attribute the profits of a foreign IP holding company back to the resident founder, taxed at the home country's standard rate. The IP box rate you achieve in Cyprus or the Netherlands may be irrelevant if your home country taxes the same profit at 25–30%. Always verify the home country CFC position before designing the structure.

Founders planning to sell within two to three years. IP holding structures require time to establish genuine substance and a credible operational track record. A structure assembled shortly before an exit will attract scrutiny from acquirer due diligence teams and may not receive the expected tax treatment on the transaction. This is a medium-term planning tool, not a pre-exit optimization.

Pillar Two: what it means (and doesn't mean) for most founders

The OECD's Pillar Two framework introduces a global minimum effective tax rate of 15% for large multinational enterprises. It is worth addressing briefly because it causes unnecessary alarm in IP holding discussions.

Pillar Two applies only to MNE groups with consolidated revenue above €750 million per year. For the overwhelming majority of founders reading this guide, it is entirely irrelevant. The IP box rates discussed above remain valid and available. The Tax Foundation's European patent box regime data confirms that the regimes continue to operate normally for in-scope companies below that threshold.

If your group has consolidated revenue above €750M, Pillar Two analysis with a Big Four advisor is required before any IP structuring decision.

Next steps

If your IP-derived revenue is already above €3–5M annually, the next step is to engage an international tax advisor to model the specific jurisdictions against your operating company locations, treaty positions, and substance options. The variables are specific enough that a guide provides orientation, not a recommendation.

If you are below that threshold but planning ahead: document R&D activity wherever it occurs, maintain clear records of who developed what and where, and build your IP documentation practice now. A strong nexus position at scale depends on clean documentation from the beginning.

If you are evaluating company formation in Cyprus or Ireland as part of a broader holding structure, Atlasway's guide to holding company structures for founders covers the broader architecture, including operating company and holding company combinations. For Cyprus-specific formation details, the Cyprus company formation guide covers entity types, timeline, and requirements. For substance requirement analysis across multiple jurisdictions, see the substance requirements guide.

Conclusion

IP holding structures are a legitimate and effective tax planning tool — when used correctly, at the right scale, and with genuine operational substance in the holding jurisdiction.

The critical variables in 2026 are these: does the entity perform real DEMPE functions in the jurisdiction, is the nexus ratio high enough to capture meaningful benefit, is the treaty network adequate to manage withholding tax on inbound royalties, and is the IP-derived revenue large enough for the savings to exceed the cost of substance?

Ireland, the Netherlands, Cyprus, Luxembourg, and Singapore are the jurisdictions worth evaluating seriously for IP holding. All others either lack a genuine IP box regime, have been rendered ineffective by BEPS, or carry risks that outweigh the benefit. Among the five, Cyprus offers the lowest effective rate and lowest substance cost; Ireland offers the strongest treaty position for US-connected structures; the Netherlands offers institutional credibility and a strong patent-holder framework.

Most early-stage founders should wait until IP revenue reaches €3–5M before the structure makes clear economic sense. That is not a failure of planning — it is an honest assessment of where the math works.

Disclaimer: The information in this guide is for research and educational purposes. It does not constitute legal or tax advice. Tax regulations, IP box regimes, and treaty arrangements change frequently — always verify current requirements with a qualified international tax advisor before taking action.

Sources: OECD BEPS Action 5 progress report (February 2026) | Irish Revenue KDB guidance | Netherlands Innovation Box — business.gov.nl | Cyprus IP Box regime — cyprustaxlife.com | Luxembourg IP regime — Harneys | Singapore IDI — EDB | European patent box regimes — Tax Foundation

The information in this article is for research and educational purposes only. It does not constitute legal or tax advice. Program rules, investment thresholds, and government fees change frequently — always verify current requirements with a licensed advisor before taking action.